Institut Catala de Retina Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01896284
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Institut Catala de Retina